AR

Abhinandhan Reddy Patlolla

Active Director Designated Partner DIN 11163400
DIN 11163400 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhinandhan Reddy Patlolla

Data last updated:

Abhinandhan Reddy Patlolla is a Designated Partner at Vaamnayi Institute Of Medical Sciences And Research Llp (since 2025).

DIN 11163400
Primary Designation Designated Partner
First Appointment 20 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Jun 20252025Active

Board colleagues of Abhinandhan Reddy Patlolla

Directorship timeline

Open interactive timeline →
Vaamnayi Institute Of Medical Sciences And Research Llp
Premium access

Shareholding and investment profile for Abhinandhan Reddy Patlolla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhinandhan Reddy Patlolla

Abhinandhan Reddy Patlolla currently holds 1 directorship: Vaamnayi Institute Of Medical Sciences And Research Llp (Designated Partner, since 20 Jun 2025).

Abhinandhan Reddy Patlolla was first appointed on 20 Jun 2025 as Designated Partner at Vaamnayi Institute Of Medical Sciences And Research Llp.

The current boards of Abhinandhan Reddy Patlolla's companies include Anusha Pendyala (Vaamnayi Institute Of Medical Sciences And Research Llp), Bhavana Tudi (Vaamnayi Institute Of Medical Sciences And Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available